Loading...
01/11 11:28
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Waystar's earnings call reveals strong financial performance with 14% revenue growth and a 40% EBITDA margin. The company demonstrates resilience with high client retention and innovation in AI. While challenges like patient payment ability and competitive pressures exist, Waystar's proactive cybersecurity and strategic M&A plans are favorable. The Q&A highlights positive utilization trends and robust revenue cycle solutions. Despite some management ambiguity, the overall sentiment is positive, supported by optimistic guidance and strong financial health, suggesting a likely stock price increase of 2% to 8%.
Revenue $256,000,000, a 14% year-over-year increase. The growth is attributed to a durable, predictable model that produces low double-digit revenue growth annually, expanding the client base, and a high net revenue retention rate of 114%.
Adjusted EBITDA $108,000,000, representing a 16% year-over-year increase. This reflects the high margin nature of the software platform and the ability to meet long-range targets of approximately 40% adjusted EBITDA margins while investing in innovation.
Subscription Revenue Increased 18% year-over-year. This growth rate is consistent with prior quarters and benefits from rapid implementations of new clients.
Volume-Based Revenue Grew 11% year-over-year. Adjusting for a previously disclosed $4,000,000 benefit in Q1 2024, the growth rate is approximately 15% year-over-year.
Unlevered Free Cash Flow $79,000,000 in Q1 2025, with a conversion ratio of 73% to adjusted EBITDA. This strong start positions the company well to achieve its long-term target of 70%.
Cash Balance $224,000,000 at March 31, 2025, after moving $24,000,000 to higher earnings short-term investments.
Net Leverage Ratio 2.5 times at March 31, 2025, a decrease of approximately a quarter turn in the quarter.
New Product Launch: Launched Altitude AI, a comprehensive suite of AI capabilities designed to help providers streamline workflows and improve financial performance.
Innovation Showcase: Demonstrated new capabilities powered by generative AI and advanced automation to prevent and address denied claims, accelerate reimbursement, and provide an integrated digital patient payment experience.
Auth Accelerate Solution: Enhanced Waystar Authorization Manager to include auto approvals, achieving an 85% auto approval rate and a 70% reduction in time spent on authorizations.
AI-Powered Software: Clients reported a more than 40% increase in overturn rates for denied claims using Waystar's AI-powered software.
Market Positioning: Waystar is recognized as the most trusted brand in healthcare payments, with a net revenue retention rate of 114% and strong demand for its differentiated cloud-based software.
Client Engagement: Over 1,244 clients now generate more than $100,000 in trailing twelve-month revenue, a 15% increase year over year.
Brand Awareness: Waystar earned top position in both unaided and aided brand awareness, making it the most recognized brand name in healthcare payments.
Operational Efficiency: Achieved a 16% year-over-year increase in adjusted EBITDA, with a margin of 42%, reflecting high-margin software platform performance.
Client Support Efficiency: 70% of service requests resolved on the same day, with 90% of inbound calls answered within thirty seconds.
Strategic Focus: Waystar is focused on delivering innovation, driving ROI for clients, and navigating economic volatility with agility.
M&A Strategy: Waystar is actively pursuing M&A opportunities that align with its technology and client base, maintaining a disciplined approach.
Economic Volatility: Waystar acknowledges increasing macro volatility and potential economic challenges, emphasizing that while no business is entirely insulated from economic cycles, their model is recession resistant.
Regulatory Risks: The new administration is discussing potential policies that could impact the US healthcare industry, but Waystar does not anticipate major impacts in 2025.
Supply Chain Challenges: Waystar has limited direct exposure to tariffs and is empathetic to potential impacts on healthcare providers, but they believe their software can help clients navigate these challenges.
Client Payment Ability: There is a concern regarding the ability of patients to pay for services, which could affect revenue, although no degradation has been observed in Q1.
Sales Cycle Lengthening: Waystar is monitoring for any lengthening of sales cycles due to economic conditions, but has not reported significant changes in client decision-making timelines.
Cybersecurity Concerns: The company emphasizes the importance of cybersecurity in client conversations, especially following a competitor's cyber attack that has influenced provider decisions.
Market Competition: Waystar is in a competitive environment, with clients actively evaluating alternatives, particularly as contracts with other vendors come up for renewal.
AI Adoption: There is a trend towards in-sourcing previously outsourced tasks due to advancements in AI, which could expand Waystar's addressable market.
Revenue Growth: Waystar delivered Q1 revenue growth of 14%, generating $256 million in revenue.
Adjusted EBITDA: Adjusted EBITDA increased by 16% year over year, reaching $108 million.
Net Revenue Retention Rate: The net revenue retention rate was 114%, indicating strong client relationships and expansion.
AI Innovations: Waystar launched Altitude AI, a suite of AI capabilities aimed at improving operational efficiency and financial performance.
Client Engagement: Waystar's Innovation Showcase saw thousands of clients and prospects engaging with new capabilities.
Cybersecurity Investments: Continued investments in cybersecurity to maintain high standards and protect client data.
M&A Strategy: Waystar is actively pursuing M&A opportunities that align with its technology and client base.
2025 Revenue Guidance: Revenue guidance raised to a range of $1,060 million to $1,022 million, with a midpoint of $1,014 million.
Adjusted EBITDA Guidance: Adjusted EBITDA guidance increased to a range of $406 million to $414 million, with a midpoint of $410 million.
Adjusted EBITDA Margin: Expected adjusted EBITDA margin remains approximately 40% for 2025.
Cash Flow Conversion: Unlevered free cash flow was $79 million, with a conversion ratio of 73%.
Net Leverage Ratio: Net leverage ratio at the end of Q1 is 2.5 times.
Shareholder Return Plan: Waystar has a strong adjusted EBITDA margin of approximately 40%, which provides ample flexibility to invest in the business, reduce debt, and pursue M&A opportunities. The company reported an unlevered free cash flow of $79,000,000 for Q1 2025, with a conversion ratio of 73% to adjusted EBITDA. The net debt to adjusted EBITDA leverage ratio is 2.5 times, indicating a strong capital structure. Waystar's allocation priorities include investing in the business to drive top-line growth, deleveraging the balance sheet, and evaluating disciplined acquisition opportunities.
Waystar's earnings call highlights strong financial metrics, including raised revenue and EBITDA guidance, a successful acquisition of Iodine, and positive client feedback. The Q&A session reveals excitement about strategic fits and cross-selling opportunities. While there are some seasonal revenue declines, the overall outlook remains optimistic with robust AI and innovation strategies. The absence of negative management responses further supports a positive sentiment. However, some sequential declines and market uncertainties temper the outlook, resulting in a 'Positive' rating rather than 'Strong positive.'
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
